Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.

Keng Hee Peh Daniel J PrzybylskiMichael J FallonJason J BergsbakenPaul R HutsonMenggang YuDustin A DemingMark E Burkard

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

The regional PMMTB non-SOC recommendations benefitted a majority of patients and additional processes were implemented to assist with non-SOC treatment accessibility.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
primary care
healthcare
peritoneal dialysis
prognostic factors
combination therapy
smoking cessation